Efficacy Study of Lucentis in the Treatment of Diabetic Macular Edema
Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the clinical efficacy of intra-vitreal injections of Ranibizumab
(Lucentis) in the treatment of Diabetic Macular Edema as compared to grid/focal laser.